PHOSPHORUS-CALCIUM BALANCE AND BONE MINERAL DENSITY OF DIFFERENT PARTS OF THE SKELETON IN CHRONIC HEMODIALYSIS PATIENTS

THE AIM of the work was to determine the relationship between the indices of phosphorus-calcium metabolism and bone mineral density (BMD) of different parts of the skeleton in patients on chronic hemodialysis. PATIENTS AND METHODS. Two-energy X-ray absorptiometry of 3 parts of the skeleton assessed by Z-criterion was used in 58 patients (m/f – 29/29, mean age 49.8 ± 13.3 years) treated by chronic bicarbonate hemodialysis (HD) on average for 74.3 ± 70.1 month. In addition to general clinical and laboratory indices in all the patients, the mean values of the level of intact parathyroid hormone (PTH) for the last year were taken intoaccount, osteocalcin and C-telopeptides of the 1 type collagen (crosslaps) were determined in 38 patients. RESULTS. Mean values of BMD by Z-criterion in the lumbar vertebrae were (-0.35 ± 1.61), proximal part of the femur (-0.70 ± 1.16) and forearm (-1.15 ± 1.78) which is lower as compared with the vertebrae (t=2.51; p=0.013). BMD of the lumbar vertebrae was higher in patients with greater body mass (Rs=0.42; p=0.0012). BMD of the proximal part of the femur has a direct correlation with the patient’s body mass (Rs=0.57; p<0.001), product Ca x P (Rs=0.30; p= 0.031) and inversely – with the blood alkaline phosphatase level (APh; Rs= -0.28; p= 0.038). BMD of the forearm was lower in patients with longer HD (Rs=-0.49; p<0.001), high levels of PTH (Rs=-0.33; p= 0.017); APh (Rs=-0.56; p<0.001), C-telopeptides of the 1 type collagen (Rs=-0.53; p<0.001) and osteocalcin (Rs=-0.36; p=0.033). CONCLUSION. The forearm is the most sensitive area of the skeleton in patients to the influence of hyperparathyroidism. Lower BMD of the forearm is more pronounced in patients with long periods of hemodialysis therapy and the diagnosis of hyperparathyroidism.

1. Taal MW, Roe S, Masud T et al. Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 2003;63(3):1116-1120

2. Matsubara K, Suliman ME, Qureshi RT et al. Bone mineral density is a predictor of survival in ESRD patients. Nephr Dial Transpl 2005; 20 [suppl 5]: v99

3. Abdelhadi M, Nordenstrom J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocr Metab 1998;83(11):3845-3851

4. Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W et al. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Adv Perit Dial 2001;17:109-113

5. Schober HC, Han HZ, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol 1998;9(7):1225-1233

6. Urena P, Bernard-Poenaru O, Ostertag A et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003; 18 (11): 2325-2331

7. Stein MS, Packham DK, Ebeling PR et al. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996;28(4):515-522

8. Nowak Z, Tlustochowicz W, Wankowicz Z. Bone mineral density in dialysis patients: the optimal region of interest depending on parathormone levels. Pol Merkuriusz Lek 2000; 9(54):822-825

9. Михеева ЮС, Румянцев АШ, Есаян АМ, Балашов АТ. Факторы риска развития остеопении и остеопороза у больных на хроническом гемодиализе. Нефрология 2003;7(4):34-40

10. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999;14(8):1922-1928

11. Ersoy FF, Passadakis SP, Tam P, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 2006;24(1):79-86

12. Tao L, Xu H, Sun M, Ikeda T. Investigation of the bone mineral density in hemodialysis patients for different terms. Hunan Yi Ke Da Xue Xue Bao 1999;24(2):177-178

13. Мазуренко ОГ, Мазуренко СО, Енькин АА с соавт. Применение двухэнергетической рентгеновской абсорбциометрии для контроля за результатами терапии альфакальцидолом у диализных больных.Нефрология 2003; 7[прил. 1]:324

14. Zayour D, Daouk M, Medawar W et al. Predictors of bone mineral density in patients on hemodialysis. Transplant Proc 2004;36(5):1297-1301

15. Yucel AE, Kart-Koseoglu H, Isiklar I et al. Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection. Ren Fail 2004;26(2):159-164

16. Nakashima A, Yorioka N, Tanji C et al. Bone mineral density may be related to atherosclerosis in hemodialysis patients. Osteoporos Int 2003;14(5):369-373

17. Malyszko J, Brzosko S, Wolczynski S et al. Bone metabolism in dialysis patient assessed by biochemical markers and densitometry. Pol Arch Med Wewn 2003; 110 (3): 967-972

18. Gerakis A, Hadjidakis D, Kokkinakis E et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 2000; 13(6):437-443

19. Matsubara K, Suliman ME, Qureshi A et al. Factors associated with bone mineral density in CKD patients. Nephr Dial Transpl 2005 June 20 [suppl 5]: v84

20. Ning JP, Sun M, Toru I et al. The relationship between bone mineral density and secondary hyperparathyroidism bone disease. Hunan Yi Ke Da Xue Xue Bao 2000;25(1):77-79.

21. Lacativa PG, de Mendonca LM, de Mattos Patricio Filho PJ et al. Risk factors for decreased total body and regional bone mineral density in hemodialysis patients with severe secondary hyperparathyroidism. J Clin Densitom 2005; 8(3):352-361

22. Pecovnik Balon B, Hojs R, Zavratnik A, Kos M. Bone mineral density in patients beginning hemodialysis treatment. Am J Nephrol 2002;22(1):14-17

23. Zsom M, Papo M, Kiss Eva et al. Bone mineral density (bmd) changes in maintenance hemodialysed (hd) patients with severe hyperparathyroidism. Nephr Dial Transpl 2005 [suppl 5]: v100